CorMedix (CRMD) Retained Earnings (2010 - 2025)

CorMedix has disclosed Retained Earnings across 15 years of filings, most recently posting -$176.6 million for Q4 2025.

• Retained Earnings for Q4 2025 came in at -$176.6 million, down 194138.46% year-over-year; the trailing twelve-month figure through Dec 2025 was -$176.6 million (down 194138.46% YoY), and the FY2025 annual result was -$176.6 million, down 194138.46% from the prior year.
• Retained Earnings came in at -$176.6 million for Q4 2025 at CorMedix, up from -$190.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $99181.0 in Q2 2021 to a low of -$336.2 million in Q1 2024.
• The 5-year median for Retained Earnings is -$88.2 million (2022), against an average of -$135.4 million.
• Across the five-year window, Retained Earnings soared 100.05% in 2021 and plunged 388894.23% in 2023, its largest moves.
• CorMedix's Retained Earnings stood at $87130.0 in 2021, then slipped by 5.04% to $82743.0 in 2022, then slumped by 388894.23% to -$321.7 million in 2023, then surged by 100.03% to $91000.0 in 2024, then tumbled by 194138.46% to -$176.6 million in 2025.
• The last three Retained Earnings figures came in at -$176.6 million (Q4 2025), -$190.6 million (Q3 2025), and -$299.2 million (Q2 2025), per Business Quant data.